--- product_id: 9127466 title: "Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer" price: "121.95 DT" currency: TND in_stock: true reviews_count: 13 url: https://www.desertcart.tn/products/9127466-her-2-the-making-of-herceptin-a-revolutionary-treatment-breast store_origin: TN region: Tunisia --- # Innovative treatment In-depth insights Cancer awareness Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer **Price:** 121.95 DT **Availability:** ✅ In Stock ## Summary > 📖 Uncover the story that changed lives! ## Quick Answers - **What is this?** Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer - **How much does it cost?** 121.95 DT with free shipping - **Is it available?** Yes, in stock and ready to ship - **Where can I buy it?** [www.desertcart.tn](https://www.desertcart.tn/products/9127466-her-2-the-making-of-herceptin-a-revolutionary-treatment-breast) ## Best For - Customers looking for quality international products ## Why This Product - Free international shipping included - Worldwide delivery with tracking - 15-day hassle-free returns ## Key Features - • **Historical Impact:** Understand the pivotal moments that shaped modern oncology. - • **Empowering Knowledge:** Gain insights that empower patients and healthcare professionals alike. - • **Inspiring Narratives:** Read compelling stories of resilience and hope in the fight against cancer. - • **Transformative Journey:** Explore the groundbreaking story behind Herceptin's development. - • **Scientific Breakthrough:** Delve into the revolutionary science that changed breast cancer treatment. ## Overview Her-2: The Making of Herceptin chronicles the groundbreaking development of Herceptin, a revolutionary treatment for breast cancer, offering readers a deep dive into the science, history, and personal stories that shaped this medical milestone. ## Description Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. Review: Fascinating and detailed. - A compelling read about the discovery of the drug Herceptin. My education crossed paths with both Dr. Dennis Salmon and Dr. John Glaspy during my internship at UCLA in 1992. Both of them were my attending physicians during my internship. In fact, my first rotation out of medical school (from UCSF) was on the solid oncology unit at UCLA and a few short months later it was on the bone marrow transplant unit. I encountered many deathly sick patients and sadly many died. I wish I knew what Dr. Slamon and Dr. Glaspy were doing at the very time of my internship to help save the lives of their patients. They are to be commended for advancing the treatments for breast cancer. All these years later I wish that my internship had started with one of the oncology attendings telling me this: "Your internship is going to suck. You will take care of devastatingly sick patients many of whom will die. You will be fatigued and get little sleep. You will become attached to them and feel the pain that they and their families go through. And often, it will be hopeless, but we want you to know that as you are on the wards taking care of them we are working on the advances that one day will help to save their lives. If I had only known about those first patients ever to receive HERCEPTIN it might have changed not only my year of internship but all the years since. I recognize that it is in the 26 years since doing my internship that many new treatments have in fact come along to save or at least add years to people's lives. It was 9 years after my internship that the drug GLEEVEC was approved--I wish it had been available to save the life of one of my patients, JK. I watched as the attendings and fellows and residents and myself were completely helpless in saving him. Robert Bazell is to be commended for not only reporting the science, but the politics and bureaucracy of bringing a life saving drug to market. Review: Amazing Miracle, Thank you Dr Slamon! - Reading this book, and yes I saw the movie...again pointed out, How Very BLESSED I am to be alive! If Dr Slamon had given up on his fight to bring Herceptin to fruition...I and a very large number of women would have been dead years ago! I was able to really experience all the problems and difficulties he and many others faced. Reading about those who fought hard for its inception increases my respect and admiration. If not for those who worked so diligently to bring these developments to life many would be dead. In 1999 I was diagnosed with this aggressive form of Cancer. I truly appreciate all those women who went before me. After 8 years on Herceptin, with an OK from Dr Slamon, My weekly Herceptin was discontinued. I have been Blessed now with 16 years of life, when I had originally been given a few months. ## Features - Used Book in Good Condition ## Technical Specifications | Specification | Value | |---------------|-------| | Best Sellers Rank | #230,689 in Books ( See Top 100 in Books ) #46 in Breast Cancer (Books) #244 in Health, Mind & Body Reference #513 in General Women's Health | | Customer Reviews | 4.5 out of 5 stars 214 Reviews | ## Images ![Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer - Image 1](https://m.media-amazon.com/images/I/51TxrJHARML.jpg) ## Available Options This product comes in different **Media Format** options. ## Customer Reviews ### ⭐⭐⭐⭐⭐ Fascinating and detailed. *by S***E on August 31, 2018* A compelling read about the discovery of the drug Herceptin. My education crossed paths with both Dr. Dennis Salmon and Dr. John Glaspy during my internship at UCLA in 1992. Both of them were my attending physicians during my internship. In fact, my first rotation out of medical school (from UCSF) was on the solid oncology unit at UCLA and a few short months later it was on the bone marrow transplant unit. I encountered many deathly sick patients and sadly many died. I wish I knew what Dr. Slamon and Dr. Glaspy were doing at the very time of my internship to help save the lives of their patients. They are to be commended for advancing the treatments for breast cancer. All these years later I wish that my internship had started with one of the oncology attendings telling me this: "Your internship is going to suck. You will take care of devastatingly sick patients many of whom will die. You will be fatigued and get little sleep. You will become attached to them and feel the pain that they and their families go through. And often, it will be hopeless, but we want you to know that as you are on the wards taking care of them we are working on the advances that one day will help to save their lives. If I had only known about those first patients ever to receive HERCEPTIN it might have changed not only my year of internship but all the years since. I recognize that it is in the 26 years since doing my internship that many new treatments have in fact come along to save or at least add years to people's lives. It was 9 years after my internship that the drug GLEEVEC was approved--I wish it had been available to save the life of one of my patients, JK. I watched as the attendings and fellows and residents and myself were completely helpless in saving him. Robert Bazell is to be commended for not only reporting the science, but the politics and bureaucracy of bringing a life saving drug to market. ### ⭐⭐⭐⭐⭐ Amazing Miracle, Thank you Dr Slamon! *by M***Y on November 3, 2016* Reading this book, and yes I saw the movie...again pointed out, How Very BLESSED I am to be alive! If Dr Slamon had given up on his fight to bring Herceptin to fruition...I and a very large number of women would have been dead years ago! I was able to really experience all the problems and difficulties he and many others faced. Reading about those who fought hard for its inception increases my respect and admiration. If not for those who worked so diligently to bring these developments to life many would be dead. In 1999 I was diagnosed with this aggressive form of Cancer. I truly appreciate all those women who went before me. After 8 years on Herceptin, with an OK from Dr Slamon, My weekly Herceptin was discontinued. I have been Blessed now with 16 years of life, when I had originally been given a few months. ### ⭐⭐⭐⭐ Wow just wow *by N***. on February 12, 2024* Thank you for developing this treatment and giving us the quick fix allowing us an opportunity to look deeper into why cancer took root in our body. Such an enlightening read on how little we count to some and how passionate you have to be to help people heal. ## Frequently Bought Together - Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer - Genentech: The Beginnings of Biotech (Synthesis) --- ## Why Shop on Desertcart? - 🛒 **Trusted by 1.3+ Million Shoppers** — Serving international shoppers since 2016 - 🌍 **Shop Globally** — Access 737+ million products across 21 categories - 💰 **No Hidden Fees** — All customs, duties, and taxes included in the price - 🔄 **15-Day Free Returns** — Hassle-free returns (30 days for PRO members) - 🔒 **Secure Payments** — Trusted payment options with buyer protection - ⭐ **TrustPilot Rated 4.5/5** — Based on 8,000+ happy customer reviews **Shop now:** [https://www.desertcart.tn/products/9127466-her-2-the-making-of-herceptin-a-revolutionary-treatment-breast](https://www.desertcart.tn/products/9127466-her-2-the-making-of-herceptin-a-revolutionary-treatment-breast) --- *Product available on Desertcart Tunisia* *Store origin: TN* *Last updated: 2026-09-12*